Sensirion Holding AG
/ Key word(s): Miscellaneous
Media Release 08.05.2024, Sensirion AG, 8712 Stäfa, Schweiz
Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery In the changing landscape of the healthcare industry, Sensirion's SLD3x series contributes to the improvement of subcutaneous drug delivery with miniature, and highly accurate digital liquid flow sensors. Customizable solutions ensure optimal dosing and enhanced patient safety for various subcutaneous therapies. For more information, please visit our product page or join our live webinar on May 23rd.
SLD3x series at a glance: Full scale flow rate (H2O) 5 ml/min About Sensirion – Experts for Environmental and Flow Sensor Solutions Sensirion is one of the world’s leading developers and manufacturers of sensors and sensor solutions that improve efficiency, health, safety, and comfort. Founded in 1998, Sensirion now employs around 1’200 people at its headquarters in Stäfa, Switzerland and in numerous international subsidiaries. Sensirion sensors can be used to measure a wide range of environmental parameters and flow rates precisely and reliably. The company’s aim is to make the world smarter with advanced sensor technology. As a pioneer in innovation, Sensirion develops solutions for the specific needs of customers and partners from the automotive, industrial, medical technology and consumer electronics markets, as well as high-quality products for cost-efficient mass production. More information and current key figures are available at www.sensirion.com. Additional features: File: Sensirion SLD3x Platform
End of Media Release |
Language: | English |
Company: | Sensirion Holding AG |
Laubisrütistrasse 50 | |
8712 Stäfa | |
Switzerland | |
Phone: | +41 44 306 40 00 |
Fax: | +41 44 306 49 06 |
Internet: | www.sensirion.com |
ISIN: | CH0406705126 |
Valor: | A2JGBW |
Listed: | Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart; SIX Swiss Exchange |
EQS News ID: | 1898195 |
End of News | EQS News Service |
|
1898195 08.05.2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.